Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-20-049920

EVP, CBO, GC & Secretary sold 10,054 shares at $14.98 ($150,609)

  • EVP, CBO, GC & Secretary acquired 10,054 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Primiano Christopher Brett · EVP, CBO, GC & Secretary

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-09-08 Exercise or conversion : show line 1 in the form +10,054 $6.54 $65,753 14,703 D
2020-09-08 Sale : show line 2 in the form −10,054 $14.98 $150,609 4,649 D
Open-market sales · 10,054 sh · avg $14.98 · $150,609

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-09-08 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −10,054 $6.54 2026-01-14 10,054 0 D
Loading xslF345X03/doc4.xml…